Literature DB >> 25801873

Plasma aldosterone and left ventricular diastolic function in treatment-naïve patients with hypertension: tissue-Doppler imaging study.

Cristiana Catena1, Nicolas Verheyen2, Stefan Pilz2, Elisabeth Kraigher-Krainer2, Andreas Tomaschitz2, Leonardo A Sechi2, Burkert Pieske2.   

Abstract

Aldosterone has hypertrophic and profibrotic effects on the heart. The relationship between plasma aldosterone levels and left ventricular diastolic function in hypertension, however, is unclear. The aim of this study was to examine this relationship in treatment-naïve hypertensive patients free of comorbidities that could affect left ventricular diastolic filling properties. In 115 patients with primary hypertension who were eating a standard diet and 100 matched normotensive controls, we measured plasma aldosterone and active renin levels and performed both conventional echocardiography and tissue-Doppler imaging for assessment of left ventricular diastolic function. Left ventricular hypertrophy was found in 21% of hypertensive patients, and diastolic dysfunction was detected in 20% by conventional echocardiography and in 58% by tissue-Doppler imaging. Patients with left ventricular diastolic dysfunction at tissue-Doppler imaging were older and more frequently men, had greater body mass index, blood pressure, alcohol intake, left ventricular mass index, relative wall thickness, and lower plasma aldosterone levels than patients with preserved diastolic function. Plasma aldosterone correlated directly with left ventricular mass index in addition to age, body mass index, and systolic blood pressure. Plasma aldosterone was also directly related to e' velocity at tissue-Doppler imaging, but this relationship was lost after multivariate adjustment. In conclusion, plasma aldosterone levels are associated with left ventricular hypertrophy but have no independent relationship with left ventricular diastolic properties in hypertensive patients.
© 2015 American Heart Association, Inc.

Entities:  

Keywords:  echocardiography; hypertrophy, left ventricular; renin

Mesh:

Substances:

Year:  2015        PMID: 25801873     DOI: 10.1161/HYPERTENSIONAHA.115.05285

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  9 in total

1.  Prevalence and prognosis of left ventricular diastolic dysfunction in community hypertension patients.

Authors:  Dan Zhou; Mengqi Yan; Qi Cheng; Xiaoxuan Feng; Songtao Tang; Yingqing Feng
Journal:  BMC Cardiovasc Disord       Date:  2022-06-13       Impact factor: 2.174

2.  Cardiovascular Risk in Patients With Takayasu Arteritis Directly Correlates With Diastolic Dysfunction and Inflammatory Cell Infiltration in the Vessel Wall: A Clinical, ex vivo and in vitro Analysis.

Authors:  Sebastiano Cicco; Vanessa Desantis; Antonio Vacca; Gerardo Cazzato; Antonio G Solimando; Anna Cirulli; Silvia Noviello; Cecilia Susca; Marcella Prete; Gabriele Brosolo; Cristiana Catena; Aurelia Lamanuzzi; Ilaria Saltarella; Maria Antonia Frassanito; Antonella Cimmino; Giuseppe Ingravallo; Leonardo Resta; Roberto Ria; Monica Montagnani
Journal:  Front Med (Lausanne)       Date:  2022-05-16

Review 3.  Current progress in clinical, molecular, and genetic aspects of adult fibromuscular dysplasia.

Authors:  Alexandre Persu; Piotr Dobrowolski; Heather L Gornik; Jeffrey W Olin; David Adlam; Michel Azizi; Pierre Boutouyrie; Rosa Maria Bruno; Marion Boulanger; Jean-Baptiste Demoulin; Santhi K Ganesh; Tomasz J Guzik; Magdalena Januszewicz; Jason C Kovacic; Mariusz Kruk; Peter de Leeuw; Bart L Loeys; Marco Pappaccogli; Melanie H A M Perik; Emmanuel Touzé; Patricia Van der Niepen; Daan J L Van Twist; Ewa Warchoł-Celińska; Aleksander Prejbisz; Andrzej Januszewicz
Journal:  Cardiovasc Res       Date:  2022-01-07       Impact factor: 10.787

4.  Short-term cardiac outcome in survivors of COVID-19: a systematic study after hospital discharge.

Authors:  Leonardo A Sechi; Gianluca Colussi; Luca Bulfone; Gabriele Brosolo; Andrea Da Porto; Maddalena Peghin; Vincenzo Patruno; Carlo Tascini; Cristiana Catena
Journal:  Clin Res Cardiol       Date:  2021-01-22       Impact factor: 5.460

5.  Plasma renin activity, serum aldosterone concentration and selected organ damage indices in essential arterial hypertension.

Authors:  Tomasz Pizoń; Marek Rajzer; Wiktoria Wojciechowska; Tomasz Drożdż; Dorota Drożdż; Marta Rojek; Krystian Gruszka; Danuta Czarnecka
Journal:  Arch Med Sci       Date:  2018-02-07       Impact factor: 3.318

6.  Adrenal Venous Sampling Could Be Omitted before Surgery in Patients with Conn's Adenoma Confirmed by Computed Tomography and Higher Normal Aldosterone Concentration after Saline Infusion Test.

Authors:  Robert Holaj; Petr Waldauf; Dan Wichterle; Jan Kvasnička; Tomáš Zelinka; Ondřej Petrák; Zuzana Krátká; Lubomíra Forejtová; Jan Kaván; Jiří Widimský
Journal:  Diagnostics (Basel)       Date:  2022-07-15

7.  Aldosterone Predicts Cardiovascular, Renal, and Metabolic Disease in the General Community: A 4-Year Follow-Up.

Authors:  Alessia Buglioni; Valentina Cannone; S Jeson Sangaralingham; Denise M Heublein; Christopher G Scott; Kent R Bailey; Richard J Rodeheffer; Riccardo Sarzani; John C Burnett
Journal:  J Am Heart Assoc       Date:  2015-12-23       Impact factor: 5.501

8.  Aldosterone-to-Renin Ratio Is Associated With Reduced 24-Hour Heart Rate Variability and QTc Prolongation in Hypertensive Patients.

Authors:  Martin R Grübler; Katharina Kienreich; Martin Gaksch; Nicolas Verheyen; Bríain Ó Hartaigh; Astrid Fahrleitner-Pammer; Winfried März; Johannes Schmid; Eva-Maria Oberreither; Julia Wetzel; Cristiana Catena; Leonardo A Sechi; Burkert Pieske; Andreas Tomaschitz; Stefan Pilz
Journal:  Medicine (Baltimore)       Date:  2016-02       Impact factor: 1.889

Review 9.  Salt, Aldosterone, and Parathyroid Hormone: What Is the Relevance for Organ Damage?

Authors:  Cristiana Catena; Gian Luca Colussi; Gabriele Brosolo; Nicole Bertin; Marileda Novello; Andrea Palomba; Leonardo A Sechi
Journal:  Int J Endocrinol       Date:  2017-09-19       Impact factor: 3.257

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.